Table 3.
Correlations Between PME-1 Expression and the Clinicopathological Characteristics of Patients with HCC
| Characteristics | PME-1 High | PME-1 Low | χ2 | P value |
|---|---|---|---|---|
| Gender | ||||
| Male | 39 | 36 | 3.405 | 0.065 |
| Female | 15 | 5 | ||
| Age | ||||
| >49y | 32 | 21 | 0.611 | 0.435 |
| ≤49y | 22 | 20 | ||
| Tumor Size | ||||
| >5cm | 34 | 19 | 2.610 | 0.106 |
| ≤5cm | 20 | 22 | ||
| Differentiation | ||||
| Poor | 36 | 19 | 3.950 | 0.047* |
| Well | 18 | 22 | ||
| Tumor Number | ||||
| Multiple | 33 | 11 | 11.016 | 0.001* |
| Single | 21 | 30 | ||
| Metastasis | ||||
| Yes | 38 | 19 | 5.607 | 0.018* |
| No | 16 | 22 | ||
| Liver Cirrhosis Status | ||||
| Present | 24 | 13 | 1.590 | 0.207 |
| Absent | 30 | 28 | ||
| Serum AFP Level | ||||
| >200ng/mL | 25 | 13 | 2.067 | 0.151 |
| ≤200ng/mL | 29 | 28 | ||
| Serum HBV Level | ||||
| >1000IU/mL | 31 | 21 | 0.360 | 0.548 |
| ≤1000IU/mL | 23 | 20 | ||
| Recurrence | ||||
| Yes | 35 | 12 | 11.780 | 0.001* |
| No | 19 | 29 |
Note: *P<0.05.
Abbreviations: HCC, hepatocellular carcinoma; HBV, hepatitis B virus; AFP, α-fetoprotein.